Cardiovascular

Reversible ADP Antagonists: New Alternatives To Clopidogrel For Anti-Platelet Therapy In Elective PCI»

Deepak Bhatt

ORLANDO—Deepak Bhatt from the VA Boston Healthcare System and Brigham & Women's Hospital, talks with Peter Goodwin about findings from the CHAMPION-PLATFORM study (using cangrelor in PCI) and the PLATO study (with ticagrelor in ACS)—testing reversible ADP antagonist agents as anti-platelet therapy, as reported at the American Heart Association Annual Meeting held in Orlando.

Central Pressure And New Goals: Should Be Hypertension Therapy Priorities»

Björn Dahlöf

A fundamental change in the way hypertension is measured, and studies to identify evidence-based blood pressure goals have been highlighted as top priorities by one of Sweden's prominent hypertension specialists, Björn Dahlöf, during the European Meeting on Hypertension.

Oncology

Multiple Myeloma: Big Survival Gains From Novel Agents In The Real World»
Evangelos Terpos

Evangelos Terpos, University of Athens

Big improvements in survival among patients with multiple myeloma were reported at the European Hematology Association annual congress in Barcelona by Greek researchers looking at the past decade of therapy with the novel agents: thalidomide, lenalidomide and bortezomib in the “real world” setting. Professor Evangelos Terpos from the University of Athens discusses his groups findings on bone metabolism under novel agent therapy and assesses the impact of these drugs on survival among patients in Greece.

Rituximab Maintenance Cuts Follicular Lymphoma Recurrence Risk In Half — Phase III PRIMA Study Results»
Gilles Salles

Gilles Salles, University of Lyon

Patients in the PRIMA study who had achieved remissions for their follicular lymphoma by means of immunochemotherapy had only half the risk of recurrence if they also received maintenance therapy with rituximab for two years compared with those who did not. Gilles Salles from the University of Lyon discussed his findings with Peter Goodwin during the 2010 European Hematology Association annual congress in Barcelona.

Global Health

John Cleland

Professor John Cleland of the London School of Hygiene & Tropical Medicine talks about the central role of family planning for tackling the linked challenge of rising global populations and climate change. He tells why a reduction of unwanted pregnancies is needed - especially in sub-Saharan Africa - as the means of relieving poverty and improving health for all. Dr Alex Ezeh, Executive Director of the African Population and Health Research Centre in Nairobi discusses the central role of Africa in population strategies for the planet. Professor Paul Wilkinson of the London School examines the real hope that rising populations - which limit progress in cutting carbon emissions and which threaten basic health - can be contained to offer a better future for everybody.

Paul Wilkinson

Tim Nicholson of the Campaign for Greener Healthcare talks about the aims of the 10:10 Campaign conducted by organisations volunteering to reduce carbon emissions by at least 10 per cent in a 12 month period; Fiona Godlee Editor in Chief of the British Medical Journal discusses her publication's involvement with raising awareness of climate change issues over the years and how they've achieved success so far as a 10:10 Campaign member; Paul Wilkinson of the London School of Hygiene & Tropical Medicine discusses the practical ways in which the School is rising to the challenge of meeting the first 12-month target and then going on to cut emissions in half by the year 2020 and 90% by 2040.